Dr. Christina Gavegnano is an Assistant Professor in the Emory School of Medicine and a Visiting Associate Professor in the Emory College of Arts and Sciences. As an Emory graduate student, Dr. Gavegnano made a discovery that is now contributing to a potential cure for HIV-1.
During the pandemic, Dr. Gavegnano developed a first-line COVID-19 treatment. When the royalty money came in, she decided to use it, along with her own savings, to fund the Gavegnano Drug Discovery Program (GDDP), a lab at Emory just for undergraduate students. The GDDP gives students hands-on research experience and a chance to participate in laboratory discovery, human trial design, and real-time collaborations with the FDA and pharmaceutical companies.
In this episode, recorded in fall 2024, Emory University President Gregory L. Fenves talks with Dr. Gavegnano about her life-saving research and how she is supporting a new generation of drug discoverers
Popular Podcasts
Crime Junkie
Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by audiochuck Media Company.
24/7 News: The Latest
The latest news in 4 minutes updated every hour, every day.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.